logo
Plus   Neg
Share
Email

Neurocrine Biosciences Inc Q4 adjusted earnings Beat Estimates

Neurocrine Biosciences Inc (NBIX) reported earnings for its fourth quarter that increased from last year.

The company's earnings totaled $34.0 million, or $0.35 per share. This compares with $18.0 million, or $0.19 per share, in last year's fourth quarter.

Excluding items, Neurocrine Biosciences Inc reported adjusted earnings of $102.2 million or $1.05 per share for the period.

Analysts had expected the company to earn $0.75 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 85.8% to $244.1 million from $131.4 million last year.

Neurocrine Biosciences Inc earnings at a glance:

-Earnings (Q4): $102.2 Mln. vs. $38.4 Mln. last year.
-EPS (Q4): $1.05 vs. $0.40 last year.
-Analysts Estimate: $0.75
-Revenue (Q4): $244.1 Mln vs. $131.4 Mln last year.

For comments and feedback contact: editorial@rttnews.com

RELATED NEWS
Follow RTT